Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Executive Vice President | December 29, 2011 | December 21, 2012 |
| AbbVie Inc.ABBV · Entity 2800 | Director | March 31, 2025 | April 02, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date December 29, 2011 · Filed December 21, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 49,432 |
Reported balance
After 2011-12-29 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2011-12-29 · Gift · Disposed 24,982 · Balance 49,432 F1: Reflects the transfer of 111,161 Abbott common shares that was exempt from Section 16. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the transfer of 111,161 Abbott common shares that was exempt from Section 16.
AbbVie Inc.
Report date March 31, 2025 · Filed April 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par valueSEC Table I · non-derivative | Direct | 386,479 |
Reported balance
After 2025-03-31 transaction · row 1
1 source rowRow 1 · 2025-03-31 · Gift · Disposed 2,450 · Balance 386,479 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 07, 2015 Filed Dec 30, 2015 17:14 UTC | AbbVie Inc. ABBV · Entity 2800 | GiftCommon stock, $0.01 par value | 2,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-016813 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 466,732 Read SEC document |
| September 10, 2015 Filed Oct 2, 2015 16:50 UTC | AbbVie Inc. ABBV · Entity 2800 | GiftCommon stock, $0.01 par value | 1,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-013708 · edgar.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 469,362 Read SEC document |
| August 28, 2015 Filed Oct 2, 2015 16:50 UTC | AbbVie Inc. ABBV · Entity 2800 | GiftCommon stock, $0.01 par value | 2,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-013708 · edgar.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 4,600 F1 · ownership.nature: The reporting person disclaims beneficial ownership of these securities. Read SEC document |
| August 28, 2015 Filed Oct 2, 2015 16:50 UTC | AbbVie Inc. ABBV · Entity 2800 | GiftCommon stock, $0.01 par value | 2,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-15-013708 · edgar.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 470,837 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionOption (right to buy) · Derivative | 65,000 | $0.00 Strike: $35.88 | $0.00 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · derivative · entry 30 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,953 Underlying: Common stock · 65,000 shares Expires 2023-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 100 | $71.17 | $7,116.50 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 29 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 513,208 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 800 | $71.16 | $56,928.00 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 28 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 513,308 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 500 | $71.16 | $35,577.50 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 27 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 514,108 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 600 | $71.15 | $42,690.00 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 26 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 514,608 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 100 | $71.15 | $7,114.50 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 25 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 515,208 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 500 | $71.14 | $35,570.00 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 24 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 515,308 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 800 | $71.13 | $56,904.00 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 23 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 515,808 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 100 | $71.13 | $7,112.50 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 22 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 516,608 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,700 | $71.12 | $120,904.00 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 21 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 516,708 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 200 | $71.12 | $14,223.00 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 20 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 518,408 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,997 | $71.11 | $142,006.67 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 19 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 518,608 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 100 | $71.11 | $7,110.50 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 18 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 520,605 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 2,200 | $71.10 | $156,420.00 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 17 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 520,705 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 200 | $71.10 | $14,219.00 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 16 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 522,905 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 2,500 | $71.09 | $177,725.00 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 15 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 523,105 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 100 | $71.09 | $7,108.50 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 14 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 525,605 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 2,800 | $71.08 | $199,024.00 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 13 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 525,705 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 200 | $71.08 | $14,215.00 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 12 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 528,505 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 2,124 | $71.07 | $150,952.68 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 11 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 528,705 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 200 | $71.07 | $14,213.00 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 10 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 530,829 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 2,300 | $71.06 | $163,438.00 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 9 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 531,029 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,800 | $71.05 | $127,890.00 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 8 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 533,329 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 100 | $71.05 | $7,104.50 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 7 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 535,129 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 700 | $71.04 | $49,728.00 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 6 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 535,229 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,300 | $71.03 | $92,339.00 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 535,929 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 200 | $71.02 | $14,204.00 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 537,229 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 758 | $71.00 | $53,818.00 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 537,429 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | Exercise / conversionCommon stock, $0.01 par value | 65,000 | $35.88 | $2,332,200.00 |
DisclosureSEC source: 0001179110-15-011606 · edgar.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 538,187 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 500 | $71.34 | $35,670.00 |
DisclosureSEC source: 0001179110-15-011607 · edgar.xml · nonDerivative · entry 26 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 473,187 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,200 | $71.33 | $85,596.00 |
DisclosureSEC source: 0001179110-15-011607 · edgar.xml · nonDerivative · entry 25 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 473,687 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 300 | $71.31 | $21,393.00 |
DisclosureSEC source: 0001179110-15-011607 · edgar.xml · nonDerivative · entry 24 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 474,887 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 2,100 | $71.30 | $149,730.00 |
DisclosureSEC source: 0001179110-15-011607 · edgar.xml · nonDerivative · entry 23 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 475,187 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 100 | $71.30 | $7,129.50 |
DisclosureSEC source: 0001179110-15-011607 · edgar.xml · nonDerivative · entry 22 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 477,287 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 700 | $71.29 | $49,903.00 |
DisclosureSEC source: 0001179110-15-011607 · edgar.xml · nonDerivative · entry 21 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 477,387 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,000 | $71.28 | $71,280.00 |
DisclosureSEC source: 0001179110-15-011607 · edgar.xml · nonDerivative · entry 20 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 478,087 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,400 | $71.27 | $99,778.00 |
DisclosureSEC source: 0001179110-15-011607 · edgar.xml · nonDerivative · entry 19 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 479,087 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 350 | $71.27 | $24,942.75 |
DisclosureSEC source: 0001179110-15-011607 · edgar.xml · nonDerivative · entry 18 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 480,487 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 11,707 | $71.26 | $834,240.82 |
DisclosureSEC source: 0001179110-15-011607 · edgar.xml · nonDerivative · entry 17 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 480,837 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 100 | $71.26 | $7,125.50 |
DisclosureSEC source: 0001179110-15-011607 · edgar.xml · nonDerivative · entry 16 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 492,544 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,200 | $71.25 | $85,500.00 |
DisclosureSEC source: 0001179110-15-011607 · edgar.xml · nonDerivative · entry 15 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 492,644 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 100 | $71.25 | $7,124.50 |
DisclosureSEC source: 0001179110-15-011607 · edgar.xml · nonDerivative · entry 14 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 493,844 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 1,936 | $71.24 | $137,920.64 |
DisclosureSEC source: 0001179110-15-011607 · edgar.xml · nonDerivative · entry 13 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 493,944 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 5,403 | $71.23 | $384,855.69 |
DisclosureSEC source: 0001179110-15-011607 · edgar.xml · nonDerivative · entry 12 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 495,880 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 100 | $71.23 | $7,122.50 |
DisclosureSEC source: 0001179110-15-011607 · edgar.xml · nonDerivative · entry 11 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 501,283 Read SEC document |
| July 29, 2015 Filed Jul 31, 2015 17:41 UTC | AbbVie Inc. ABBV · Entity 2800 | SaleCommon stock, $0.01 par value | 2,200 | $71.22 | $156,684.00 |
DisclosureSEC source: 0001179110-15-011607 · edgar.xml · nonDerivative · entry 10 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 501,383 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.